CompletedPhase 2NCT00004010
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
Studying Nodular lymphocyte predominant Hodgkin lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Kara Kelly, MDHerbert Irving Comprehensive Cancer Center
- Intervention
- bleomycin sulfate(biological)
- Enrollment
- 99 target
- Eligibility
- 21 years · All sexes
- Timeline
- 1999 – 2008
Study locations (30)
- Long Beach Memorial Medical Center, Long Beach, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States
- David Grant Medical Center, Travis Air Force Base, California, United States
- Children's Hospital of Denver, Denver, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- University of Chicago Cancer Research Center, Chicago, Illinois, United States
- Indiana University Cancer Center, Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
- University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
- CCOP - Kalamazoo, Kalamazoo, Michigan, United States
- University of Minnesota Cancer Center, Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center, Rochester, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00004010 on ClinicalTrials.govOther trials for Nodular lymphocyte predominant Hodgkin lymphoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06098430Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)St. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT05886036Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM TrialNational Cancer Institute (NCI)
See all trials for Nodular lymphocyte predominant Hodgkin lymphoma →